This is a preview of subscription content, log in via an institution to check access.
ORIGINAL RESEARCH PAPERS
Lynch, T. J. et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 29 April 2004 (doi:10.1056/NEJMoa040938)
Paez, J. G. et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 29 April 2004 (doi:10.1126/science.1099314)
Rights and permissions
About this article
Cite this article
Hutchinson, E. No longer in the dark. Nat Rev Cancer 4, 415–416 (2004). https://doi.org/10.1038/nrc1376
Issue Date:
DOI: https://doi.org/10.1038/nrc1376
- Springer Nature Limited